Measuring the cost effectiveness of HIV prevention interventions in the US: pitfalls and problems
Appl Health Econ Health Policy
.
2015 Apr;13(2):129-33.
doi: 10.1007/s40258-015-0158-5.
Author
Fred Joseph Hellinger
1
Affiliation
1
Agency for Healthcare Research and Quality, Rockville, MD, USA, fred.hellinger@ahrq.hhs.gov.
PMID:
25724918
DOI:
10.1007/s40258-015-0158-5
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cost-Benefit Analysis*
HIV Infections / economics*
HIV Infections / prevention & control*
Humans
Primary Prevention / economics*
Secondary Prevention / economics*